Deep Brain Stimulation I: Basic Principles and Programming in Movement Disorders
Sunday April 23, 2017 1:00 pm to 3:00 pm
Jill Ostrem MD
Deep brain stimulation is widely used to treat advanced, medication-resistant movement disorders, including essential tremor, Parkinson's disease, and dystonia. Understanding the DBS device, proper patient selection, and optimized postoperative management is essential to achieve successful outcomes with DBS, maximize patient benefits, and minimize adverse effects or complications. Each of these key issues will be discussed, with an emphasis on practical information for the clinician. This course has been divided into two sequential sessions, and those registering for the course are encouraged to participate in both sessions for a comprehensive overview of the topic. Part I will focus on basic DBS principles and programming issues in movement disorders. Part II will focus on more advanced DBS issues in movement disorders and also highlight DBS in non-movement disorders conditions. These programs will include a case-based discussion highlighting patient candidacy and management of DBS, and will occur at the end each session.
This program complements C53: Deep Brain Stimulation II: Advanced Management in Movement Disorders and Applications Beyond Movement Disorders, but covers independent topics.
Participants should be able to describe the rationale for the use of DBS and the patients for whom the treatment is most indicated and have a general understanding and appreciate the principles of initial DBS stimulator activation and programming.
Medical Knowledge, Patient Care
Program Speakers - Tentative
1:00 PM - 1:10 PM
Jill L. Ostrem MD
1:10 PM - 1:40 PM
Overview of DBS, Current Indications, Patient Selection, Basics of Surgery
Leonard Verhagen Metman MD, PhD
1:40 PM - 2:35 PM
The Art and Science of Basic DBS Stimulation Programming (Focus PD and ET)
Michael Pourfar MD
2:35 PM - 3:00 PM
Jill L. Ostrem, MD
Dr. Ostrem has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Neurocrine and Adamas.
Michael Pourfar, MD
Dr. Pourfar has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Medtronic and Abbott.
Leonard Verhagen Metman, MD, PhD
Dr. Verhagen Metman has nothing to disclose.
Ready to register for the 2018 AAN Annual Meeting?